A higher bar - Vermont's new law on marketing prescribed products

New England Journal of Medicine

Volumn 361, Issue 1, 2009, Pages 8-9

  Steinbrook, Robert ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FINANCIAL MANAGEMENT; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; LAW; MEDICAL PRACTICE; PHYSICIAN; PRIORITY JOURNAL; SHORT SURVEY; UNITED STATES;

EID: 67649658246     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp0904719     Document Type: Article

References (5)

1. Commonwealth of Massachusetts. Pharmaceutical and Medical Device Manufacturer Conduct. 105 CMR 970.000. (Accessed June 11, 2009, at http://www.mass.gov/Eeohhs2/docs/dph/regs/105cmr970.pdf.)
2. State of Vermont. An act relating to the marketing of prescribed products. S.48. (Accessed June 11, 2009, at http://www.leg.state.vt.us/database/ status/summary.cfm?Bill=S%2E0048&Session=2010.)
3. Pharmaceutical marketing disclosures July 1, 2007-June 30, 2008: report of Vermont Attorney General William H. Sorrell. April 2009. (Accessed June 11, 2009, at http://www.atg.state.vt.us/display.php?smod=151.)
4. Physician Payments Sunshine Act of 2009. S.301. (Accessed June 11, 2009, at http://www.thomas.gov.)
5. Steinbrook R. Disclosure of industry payments to physicians. N Engl J Med 2008;359:559-561